NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
IT Modernization Driving AI Efficiency
Federal agencies are under pressure to modernize IT systems as AI-driven missions demand faster, more secure and resilient infrastructure.
20m read -
How Tech Can Bridge Gaps in Rural Healthcare Data Struggles
Prescription price transparency and nationwide data sharing are among the areas in which officials say technology can reduce costs.
4m read -
Army Launches Joint Innovation Outpost to Accelerate Battlefield Capabilities
At Fort Bragg, the XVIII Airborne Corps’ Joint Innovation Outpost connects soldiers, engineers and industry to accelerate battlefield capability development.
23m listen -
Inside the Navy’s Push for Resilient, AI-Enabled Command Centers
Officials outline how the Navy is modernizing Maritime Operations Centers with AI, modular tech and resilient cloud architectures.
5m read
